SHH · 600664.SS
Harbin Pharmaceutical Group Co., Ltd.
CN¥5.55+CN¥0.26 (+4.91%)
Harbin Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.71% below the high.
Loading market information…
SHH · 600587.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shinva Medical Instrument Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.97% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shinva Medical Instrument Co., Ltd.’s forward annual dividend is CN¥0.20 per share, paid semi-annual. The forward yield is 1.61% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Shinva Medical Instrument Co., Ltd.’s next earnings report is currently expected on Oct 31, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shinva Medical Instrument Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1943 and headquartered in Zibo, China, Shinva Medical Instrument Co., Ltd. is a prominent provider of medical instruments and equipment within the People's Republic of China. The company's extensive product portfolio spans a wide array of specialized areas. These include comprehensive solutions for central sterile supply departments (CSSD), pharmaceutical manufacturing, radiotherapy, and digital operating rooms. They also cater to dental practices, medical environmental protection, and experimental animal care. Furthermore, their range encompasses in vitro diagnostic reagents and instruments, as well as biomedical materials and supplies. Beyond these, Shinva also manufactures pharmaceutical machinery and air purification systems.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥5.55+CN¥0.26 (+4.91%)
Harbin Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.71% below the high.
CN¥18.01-CN¥0.12 (-0.66%)
Sinocare Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.37% below the high.
CN¥5.03+CN¥0.03 (+0.6%)
C.Q. Pharmaceutical Holding Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.12% below the high.
CN¥16.27+CN¥0.06 (+0.37%)
Tianjin Ringpu Bio-Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.4% below the high.
CN¥19.09-CN¥0.70 (-3.54%)
Amoy Diagnostics Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.89% below the high.
CN¥18.26+CN¥0.11 (+0.61%)
Aurisco Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.68% below the high.
CN¥11.84+CN¥0.10 (+0.85%)
Edan Instruments, Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.52% below the high.
CN¥40.07-CN¥0.98 (-2.39%)
Xiangyu Medical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 57.82% below the high.
